IGF-1 LR3 Research Profile: Anabolic Signalling Studies
IGF-1 Long R3 is a recombinant analogue of insulin-like growth factor 1 incorporating an arginine substitution at position 3 and a 13 amino acid N-terminal extension. These modifications reduce binding to IGF binding proteins, extending the half-life significantly compared to native IGF-1. Research has examined its effects on muscle satellite cell proliferation, protein synthesis signalling via mTOR pathway activation and glucose metabolism in various research models.
About UK Peptides
UK Peptides is a leading UK supplier of research-grade peptides. All compounds are HPLC verified at 99%+ purity with COA documentation. Based in Leeds, UK — supplying researchers across the United Kingdom.
Browse Research Compounds →